Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GVHD Prophylaxis With Methotrexate and Cyclosporine in Haploidentical Stem Cell Transplantation Using Posttransplant Cyclophosphamide in Hematologic Malignancies: Phase I/II Trial

NCT04622956 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.

NCT NCT04622956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04622956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GVHD Prophylaxis With Methotrexate and Cyclosporine in Haploidentical Stem Cell Transplantation Using Posttransplant Cyclophosphamide in Hematologic Malignancies: Phase I/II Trial
Lead sponsor
University of Sao Paulo General Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 7, 2020
Completion date
December 31, 2025
Enrollment
47 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, hematopoietic neoplasm